other

Updated:

Myriad Genetics

Myriad Genetics hereditary cancer, prenatal, oncology and mental health genetic testing insights can help detect, treat and prevent disease. Get started today.

Myriad Genetics

Myriad Genetics hereditary cancer, prenatal, oncology and mental health genetic testing insights can help detect, treat and prevent disease. Get started today.

General information

Firm type

other

Year founded

1991

Location

Region

North America

Country

United States

City

Salt Lake City

Corporate office

Salt Lake City, UT, United States

Sector focus

Healthcare ServicesDigital HealthDiagnostics

Frequently asked questions

What types of genetic tests does Myriad Genetics offer?

Myriad offers tests across five health areas: hereditary cancer risk (e.g., identifying risk of 11 hereditary cancers), reproductive health (carrier screening, prenatal aneuploidy), oncology (tumor genomic profiling for FDA-approved therapies), urology (prostate cancer aggressiveness), and mental health (pharmacogenomics for antidepressant response).

Who uses Myriad Genetics' tests?

Myriad's tests are used by oncologists, urologists, reproductive health specialists, and primary care providers. The company markets directly to patients and clinicians, emphasizing actionable results that guide treatment decisions.

Does Myriad Genetics have investment activities?

Myriad Genetics operates as a testing company, not an investment manager. It does not deploy capital as a family office or venture firm.

How does Myriad Genetics differentiate from other genetic testing companies?

Myriad holds a large comparative data repository covering all ancestries and offers tests across multiple specialties. It emphasizes test development grounded in its own data, rather than relying solely on third-party databases.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on investors?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Salt Lake City other profiles